Download Peer Reviewed Original Articles Published July 1, 2001

BOOK CHAPTERS PUBLISHED JULY 1, 2004 - JUNE 30, 2005
Artsob H (2005). Emergent and re-emergent infections in Rochon M, Goldern M (eds). The status of Hygiene.29-45.
Artsob H, Campbell, Conlan W, Dunn P, Fry S, George F, Graham A, Groves D, Hays T, Peat B, Ridgway A, Stokes R,
Thompson L, & Wagener S (2004). Laboratory Biosafety Guidelines. Health Canada H39/4/49-200E, ISBN 0-066237722-2.1-113.2.
Bow EJ. Chapter 4: Assessment of the Risk for Invasive Fungal Infection Among Oncology Patients. In: Fungal
Infections in the Immunocompromised Patient. Wingard JR, Anaissie EJ (eds). Boca Raton, FL: Taylor & Francis
Group, 2005: 97-128.
Bow EJ. Chapter 47: Approach To Infection In Patients Receiving Cytotoxic Chemotherapy for Malignancy. In:
Principles of Critical Care Hall JB, Schmidt GA, Wood LDH (eds), McGraw-Hill Inc., New York, 3rd Edition, 2005: 735770.
Feldmann H, Geisbert TW, Jahrling PB, Klenk HD, Netesov SV, Peters CJ, Sanchez A, Swanepoel R, Volchkov VE
(2004). Filoviridae. In: Virus Taxonomy, VIIIth Report of the ICTV (C.M. Fauquet, M.A. Mayo, J. Maniloff, U.
Desselberger, and L.A. Ball, eds), 645-653. Elsevier/Academic Press, London.
Gilmour MW, Lawley TD, Taylor DE. November 2004, posting date. Chapter 2.2, The Cytology of Bacterial
Conjugation. In R. Curtiss III (Editor in Chief), EcoSal-Escherichia coli and Salmonella: Cellular and Molecular Biology .
[Online.] http://www.ecosal.org. ASM Press, Washington, D.C.
Hayden FG and Aoki FY. Amantadine, Rimantadine, and Related Agents. In: Yu VL, Edwards G, McKinnon PS,
Peloquin C, Morse GD, Potoski BA (Eds.), Antimicrobial Therapy and Vaccines, Vol. II: Antimicrobial Agents, 2nd Ed.
ESun Technologies, LLC, Pittsburgh, PA, 2002, pp. 705-729 (released March 2005).
Hayden FG and Aoki FY. Influenza Neuraminidase Inhibitors (Oseltamivir and Zanamivir). In: Yu VL, Edwards G,
McKinnon PS, Peloquin C, Morse GD, Potoski BA (Eds.), Antimicrobial Therapy and Vaccines, Vol. II: Antimicrobial
Agents, 2nd Ed. ESun Technologies, LLC, Pittsburgh, PA, 2002, pp. 773-789 (released March 2005).
Hensley L, Jones SM, Feldmann H, Jahrling PB, Geisbert TW (2005). Ebola and Marburg viruses; pathogenesis and
development of countermeasures. Current Molecular Medicine 5: 777-788.
Keith K., S. Wagener, 2004, Community Relations for High-Containment Laboratories, Anthology of Biosafety, VI;
Biosafety Level 3, pp 193-210.
Khaliq Y, Forgie S and Zhanel GG. Upper respiratory infections. In: Pharmacotherapy: A Pathophysiologic Approach.
DiPiro J eds. 6th edition, McGraw Hill, New York, 2005.
Light RB. Antimicrobial Therapy. Chapter 23 In: Acute Resuscitation and Crisis Management – Acute Critical Events
Simulation (ACES) Syllabus. Neilipovitz, D. (Ed.), CRI – ICR Publications, Ottawa, 2005.
Mary York, K. Bernard, et al. 2004 Identification of Gram-positive Bacteria. In Clinical Microbiology Procedures
Manual 2nd ed. ASM Press Washington DC.
Ng, L-K. and I. Martin. Jan/Feb. 2005. The laboratory diagnosis of Neisseria gonorrhoeae. Canadian STI best
practice laboratory guidelines. Can J. Infect. Dis. Med. Microbiol. 16:15-16.
Nicolle LE. “Urinary Tract Infection” P. 411-417 in Greenberg A (ed). Primer on Kidney Diseases (4th ed) National
Kidney Foundation, Elsevier Saunders, Philadelphia 2005.
Osiowy, C. (2005) Ligase Chain Reaction. In “Medical Biomethods Handbook” Eds. John M. Walker and Ralph
Rapley. Humana Press, Totowa, NJ.
Pagotto F, Corneau N, Scherf C, Clark C, Farber J. 2005. Molecular typing and differentiation of foodborne
pathogens, In: Fratamico PM, Bhuna AK, Foodborne pathogens: microbiology and molecular biology. Horizon
Scientific Press, Ltd.
Plourde, P. A Challenge to the Medical Community: Responding to HIV/AIDS in sub-Saharan Africa, one physician at
a time, in: AIDS in Africa: Engaging Canadians Conference Anthology, Health Partners International of Canada, 2005.
Rosser SJ, and Bow EJ. Infections in Neutropenic Hosts. In: Evidence-Based Infectious Diseases. Loeb M, Smieja M,
Smaill F. (eds), BMJ Publishing Group, London, UK. 2004: 241-256.
Smith HS and Zhanel GG. Fluoroquinolone Resistance Associated Gene Mutations in Streptococcus pneumoniae. In:
Encyclopedia of Diagnostic Genomics and Proteomics (EDGP). Fuchs and Podda Eds. Marcel Dekker, Inc. New York,
New York, 2004.
Somorjai RL, M. Alexander, R. Baumgartner, S. Booth, C. Bowman, A. Demko, B., M. Mandelzweig, A.E. Nikulin, N.
Pizzi, E. Pranckeviciene, R. Summers & P. Zhilkin. Confronting and meeting the challenges of biomedical data
analysis. Kluwer Academic Publishers "Artificial Intelligence Methods and Tools for Systems Biology”, Francisco
Azuaje, Werner Dubitzky (eds.) 2004.
Wahl-Jensen V, Feldmann H, Sanchez A, Zaki SR, Rollin PE, Peters CJ (2006). Filovirus infections. In: Tropical
infectious diseases: principles, pathogens and practice. (Guerrant RL, Walker DH, Weller PF, eds.), 2nd edition,
Philadelphia, Elsevier Churchill, Livingstone.
Wahl-Jensen V, Stroeher U, Schnittler, HJ, Feldmann H (2005). Current opinion on Ebola virus pathogenesis. Nova
Acta Leopoldina NF 92, Nr. 344: 147-154.
Wittmeier L., S. Wagener, 2004, Treatment of Solid and Liquid Biowaste and ISO Registration of the Process,
Anthology of Biosafety, VI; Biosafety Level 3, pp 211-228.
Zhanel George G. and Ayman M. Noreddin. Pharmacokinetics and Pharmacodynamics of the New Generation
Quinolones. In: Recent Advances in Antimicrobial Agents and Chemotherapy, Global reviews, 2004.
Zhanel GG and Neuhauser M. The ketolides. In: Antimicrobial Therapy and Vaccines: Amtimicrobial Agents. Yu V
eds. ESun Technologies, LLC, Pittsburgh, PA, 2005.